SOPHiA GENETICS (SOPH) Accumulated Expenses (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Accumulated Expenses data on file, last reported at $20.7 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses rose 56.89% year-over-year to $20.7 million; the trailing twelve-month figure through Dec 2025 stood at $20.7 million (up 56.89% YoY), and the FY2025 full-year result was $20.7 million, up 56.89% from the prior year.
• Accumulated Expenses improved to $20.7 million in Q4 2025, from $16.7 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $20.7 million in Q4 2025 to a low of $10.5 million in Q1 2023.
• A 5-year average of $14.2 million and a median of $13.8 million in 2023 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses jumped 75.88% in 2021 and tumbled 31.63% in 2023, its largest moves.
• Tracing SOPH's Accumulated Expenses over 5 years: stood at $16.0 million in 2021, then slipped by 9.18% to $14.5 million in 2022, then rose by 22.77% to $17.8 million in 2023, then slipped by 25.78% to $13.2 million in 2024, then soared by 56.89% to $20.7 million in 2025.
• Business Quant data shows SOPH's Accumulated Expenses at $20.7 million in Q4 2025, $16.7 million in Q3 2025, and $13.7 million in Q2 2025.